Moderna's request for FDA emergency authorization after the COVID-19 vaccine indicates 94% efficacy
It's on track to produce 20 million doses for the U.S. by the end of December.
Moderna reported on Monday that it had filed an application with the United States
Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) for its COVID-19 vaccine.
Pfizer's public FDA hearing—a key phase in the approval process—is set for Dec. 10, and the FDA could make its final approval announcement soon afterward.
Public health authorities and drug manufacturers need to alert patients that coronavirus vaccine can have some significant side effects, so they know what to expect and don't panic about receiving a second dose, doctors advised CDC counselors at Monday's conference. Like any other vaccines, they do have side effects like Fever, aches from Pfizer, modern jabs are not dangerous, but they can be intense for others.